Search

Luis A. Diaz, MD, has been named the Head of the Division of Solid Tumor Oncology in the Department of Medicine at Memorial Sloan Kettering (MSK). An accomplished physician, pioneering researcher, and leader in the field of clinical oncology, Dr. Diaz most recently served as an associate professor of oncology at the Johns Hopkins University School of Medicine. Dr. Diaz formally assumes the role as David Spriggs, MD, steps down after nearly 13 years.

… Monday, April 17, 2017 Luis A. Diaz, MD , has been named the Head of the Division of Solid Tumor Oncology in the Department of Medicine at Memorial Sloan Kettering (MSK). An accomplished physician, pioneering researcher, and leader in the field of clinical oncology, Dr. Diaz most recently served as an

In clinical trials for cancer, it is standard for clinicians rather than patients to report adverse symptom side effects from treatments, such as nausea and fatigue. At present, patient self-reporting, although important, is not a well studied source of this information. A new longitudinal study from researchers at Memorial Sloan Kettering Cancer Center finds that while clinicians' and patients' reporting of treatment side effects are very different from each other, together they provide a more complete, clinically meaningful picture of the treatment experience.

… Monday, November 16, 2009 In clinical trials for cancer, it is standard for clinicians rather than patients to report adverse symptom side effects from treatments, such as nausea and fatigue. At present, patient self-reporting, although important, is not a well studied source of this information. A new

For many people with lung cancer, targeted therapies can provide effective, long-term control of their disease with fewer side effects than chemotherapy.

… Wednesday, January 1, 2020 Middle school chorus and orchestra teacher Melissa Crouse had lived in the Pittsburgh area her whole life. But on a trip to visit her brother in southwest Florida, she decided on a whim to apply for teaching jobs there. The single mom, then 51, quickly received an offer. “Three

A five-year grant of more than $1.4 million will fund a program to train nurses in helping survivors achieve the best possible quality of life after cancer.

… Monday, October 17, 2011 A five-year grant worth more than $1.4 million from the National Cancer Institute will enable City of Hope and Memorial Sloan Kettering Cancer Center to train nurses working with cancer survivors who are transitioning from active treatment to survivorship care. Nearly 12 million

Read about the latest MSK research to make CAR T therapy effective against solid tumors.

… Tuesday, September 3, 2024 When Marylou Barton heard her biopsy results, she held her daughter Kristin’s hand while they both sobbed in the doctor’s office. The mesothelioma — a rare and aggressive cancer that arose in the lining of Marylou’s lungs — appeared to have spread. She likely had about a year

A new clinical and research center at Memorial Sloan Kettering is dedicated to improving the care of young people with cancer.

… Friday, October 1, 2021 Dear MSK Community, Getting diagnosed with cancer at any age is a blow, but it’s particularly hard for someone who had just gotten started in life, only to be forced to put their dreams on hold. Unfortunately, it’s happening more often. Although overall cancer cases are declining

Restrictions due to COVID-19 are leaving many feeling isolated or lonely. MSK Psychologist Kelly Trevino, PhD, shares simple ways to find meaning and stay connected during this time.

… Tuesday, September 15, 2020 Just a few months ago, the phrase “social distancing” was not a part of our everyday vocabulary. But now, distancing from others to stay safe is the new normal and these restrictions have left many feeling isolated or lonely. Even before the pandemic, approximately one-quarter

The list acknowledges and celebrates healthcare leaders who envision a better future for all New Yorkers and constitute New York’s ever-expanding and constantly improving healthcare system.

… Monday, October 31, 2022 Selwyn M. Vickers, M.D., FACS , President and CEO of Memorial Sloan Kettering Cancer Center (MSK), has been named to amNY Metro  and  PoliticsNY ’s Power Players in Healthcare list. The list acknowledges and celebrates healthcare leaders who envision a better future for all New

Memorial Sloan Kettering Cancer Center (MSK) announces the November 2022 awards and appointments.

… Thursday, December 1, 2022 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Tania Bubb Tania Bubb Elected President of The Association for Professionals in Infection Control and Epidemiology Tania Bubb, PhD, RN, Senior Director of Infection Control, has been

New findings on several important lung cancer clinical trials were presented at the 2025 Annual Meeting of the American Society of Clinical Oncology.

… Monday, June 2, 2025 Researchers from Memorial Sloan Kettering Cancer Center (MSK) reported important advances in the treatment of lung cancer  at the annual meeting of the American Society of Clinical Oncology (ASCO), held May 30 to June 3 in Chicago. Scientists presented promising results on three